Showing results (261-270 of 831) with videos related to
Sort By:
Pageof 84
Journal of Diabetes and Its Complications|September 16, 2023
Vitamin D deficiency and development of complications in individuals with type 1 and type 2 diabetes: A cohort studyNinna Hahn Tougaard, Tine Willum Hansen, Peter RossingDiabetes Research and Clinical Practice|May 22, 2018
Stratification of type 2 diabetes based on routine clinical markersNarges Safai, Ashfaq Ali, Peter Rossing, et al.Lancet (London, England)|November 9, 2010
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialDick de Zeeuw, Rajiv Agarwal, Michael Amdahl, et al.Journal of Clinical Medicine|June 5, 2019
Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System InhibitorsMie K Eickhoff, Claire C J Dekkers, Bart J Kramers, et al.Journal of Diabetes and Its Complications|August 30, 2025
Burden and progression of arterial calcification in type 1 diabetes predicts future cardiovascular diseaseHenrik Ø Hjortkjær, Peter Rossing, Klaus F KofoedDiabetologia|December 6, 2014
SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetesMarine Germain, Marcus G Pezzolesi, Niina Sandholm, et al.Journal of Diabetes and Its Complications|October 29, 2024
Effects of probiotics and fibers on markers of nephropathy, inflammation, intestinal barrier dysfunction and endothelial dysfunction in individuals with type 1 diabetes and albuminuria. The ProFOS StudyElisabeth B Stougaard, Ninna Hahn Tougaard, Suvanjaa Sivalingam, et al.Journal of Diabetes and Its Complications|March 15, 2018
Serum uric acid and progression of diabetic nephropathy in type 1 diabetesS Pilemann-Lyberg, M Lindhardt, Frederik Persson, et al.BMC Endocrine Disorders|June 26, 2012
A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and designPeter Lommer Kristensen, Ulrik Pedersen-Bjergaard, Henning Beck-Nielsen, et al.Diabetes, Obesity & Metabolism|July 7, 2023
Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetesViktor Rotbain Curovic, Morten B Houlind, Marjolein Y A M Kroonen, et al.Pageof 84